Analysts think OCGN stock price could increase by 1213%
Mar 12, 2025, 11:25 AM
24.28%
What does OCGN do
Ocugen is a biopharmaceutical company based in Malvern, Pennsylvania, focused on gene and cell therapies for eye diseases, including inherited retinal disorders. The company also develops inhalation-based vaccines for COVID-19 and seasonal flu.
6 analysts think OCGN stock price will increase by 1213.22%. The current median analyst target is $7.14 compared to a current stock price of $0.54. The lowest analysts target is $4.04 and the highest analyst target is $8.40.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
